BioMarin Pharmaceutical
BMRN
#1728
Rank
S$15.36 B
Marketcap
S$79.30
Share price
-0.02%
Change (1 day)
15.53%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): S$57.54 Million

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$3.65 Billion. In 2025 the company made an earning of S$0.62 Billion a decrease over its 2024 earnings that were of S$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$57.54 M-90.76%
2025 S$0.62 B-10.94%
2024 S$0.69 B187.31%
2023 S$0.24 B26.07%
2022 S$0.19 B-298.51%
2021 -S$97.3 Million78.04%
2020 -S$54.65 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.19 Billion297.78%
2017 -S$46.33 Million-95.68%
2016 -S$1.08 Billion437.12%
2015 -S$0.2 Billion23.91%
2014 -S$0.17 Billion-29.25%
2013 -S$0.23 Billion49.23%
2012 -S$0.16 Billion171.11%
2011 -S$56.34 Million103.01%
2010 -S$27.75 Million-3903.54%
2009 S$0.72 M-98.31%
2008 S$43.15 M-189.7%
2007 -S$48.12 Million51.02%
2006 -S$31.86 Million-61.58%
2005 -S$82.92 Million-56.59%
2004 -S$0.2 Billion95.13%
2003 -S$97.88 Million12.09%
2002 -S$87.32 Million73.19%
2001 -S$50.42 Million18.32%
2000 -S$42.62 Million19.65%
1999 -S$35.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$10.05 B 17,735.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.58 Billion-1,124.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.15 Billion-352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.10 B 81.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.38 B 578.94%๐Ÿ‡บ๐Ÿ‡ธ USA